Long-Term Assets: The sum of all assets classified as non-current.
Quantum Biopharma Ltd. (QNTM) had Long-Term Assets of $4.95M for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
-- |
|
$-9.25M |
|
-- |
|
-- |
|
$4.85M |
|
$-4.85M |
|
$-4.91M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-4.85M |
|
$-4.71M |
|
3.02M |
|
3.02M |
|
$-3.23 |
|
$-3.23 |
|
Balance Sheet Financials | |
$10.34M |
|
$0.07M |
|
Long-Term Assets |
$4.95M |
$15.30M |
|
$13.25M |
|
-- |
|
-- |
|
$13.25M |
|
$2.05M |
|
$-2.68M |
|
$2.05M |
|
3.47M |
|
Cash Flow Statement Financials | |
$-6.21M |
|
$-2.71M |
|
$4.42M |
|
$6.00M |
|
$1.50M |
|
$-4.50M |
|
$1.14M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.78 |
|
-- |
|
-- |
|
-- |
|
1.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-477.10% |
|
364.66% |
|
-63.84% |
|
-477.10% |
|
$0.59 |
|
$-2.06 |
|
$-2.06 |